testo-alternativo
Predicting Kidney Health: The Future of Nephrology Unveiled

Inside Nephrology: A Weekly Review

Nefrologia

Predicting Kidney Health: The Future of Nephrology Unveiled

This episode explores the evolving frontiers of nephrology, from early prediction of diabetes through urinary markers to the clinical challenges of CAR T-cell-related nephrotoxicity. We discuss advances in DMAND therapy, AI-based transplant monitoring, and the growing interplay between nephrology, cardiology, and infectious diseases. A focused look at how innovation is reshaping kidney care and multi-organ management.

Login or Register to listen to this episode

Bibliography

Schork A et al. Differential risk assessment in persons at risk of type 2 diabetes using urinary peptidomics. Metabolism. 2025;167:156174. doi:10.1016/j.metabol.2025.156174


Teng YKO et al. Disease-modifying anti-nephropathic drugs (DMANDs): a definition proposed by the ERA. Nephrol Dial Transplant. 2025;40(6):1243–7. doi:10.1093/ndt/gfaf033


Zlamal J et al. Refractory autoimmune heparin-induced thrombocytopenia following cardiac surgery. J Thromb Haemost. 2025;23(6):2035–8. doi:10.1016/j.jtha.2025.03.024


Hagen M et al. Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients. Lancet Rheumatol. 2025;7(6):e424–33. doi:10.1016/S2665-9913(25)00091-8


Xu Z et al. Diagnostic imaging confusion in infectious spondylitis. J Orthop Surg Res. 2025;20(1):496. doi:10.1186/s13018-025-05781-5


Amano M et al. Validation of guideline recommendation on SCD prevention in HCM. JACC Heart Fail. 2025;13(6):1014–26. doi:10.1016/j.jchf.2024.12.006


Hazenbroek M et al. Patient-controlled tacrolimus self-monitoring. Br J Clin Pharmacol. 2025;91(6):1560–8. doi:10.1111/bcp.16121


Stea ED et al. Multidisciplinary consensus on atypical HUS diagnosis and management. Pharmacol Res. 2025;216:107714. doi:10.1016/j.phrs.2025.107714


Awdishu L et al. KDIGO 2024 guideline primer for pharmacists. Am J Health Syst Pharm. 2025;82(12):660–71. doi:10.1093/ajhp/zxaf044


Vandal M et al. CD2AP at the junction of nephropathy and Alzheimer’s disease. Mol Neurodegener. 2025;20(1):63. doi:10.1186/s13024-025-00852-x

Comments

Please Login to leave a comment.

No comments yet. Be the first to comment!